Weak sterling boosts GlaxSmithKline as new CEO takes over
April 26, 2017 at 07:10 AM EDT
LONDON, April 26 (Reuters) - GlaxoSmithKline's new chief executive reported slightly better than expected first-quarter results on Wednesday, keeping the drugmaker on track to hit financial targets in 2017 as it braces for generic competition to blockbuster lung drug Advair.